P A Jones
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 4
- Protease and Inhibitor Mechanisms 2
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 10
- Cancer-related gene regulation 5
- RNA modifications and cancer 4
- Oncology top 5%
- Cancer-related Molecular Pathways 4
- Genetics top 5%
-
- Genetic factors in colorectal cancer 2
-
- Bladder and Urothelial Cancer Treatments 4
P A Jones
19 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 966
- Molecular Biology 4.3k
- Oncology 763
- Genetics 678
- Pathology and Forensic Medicine 359
Countries citing papers authored by P A Jones
This map shows the geographic impact of P A Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P A Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P A Jones more than expected).
Fields of papers citing papers by P A Jones
This network shows the impact of papers produced by P A Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P A Jones. The network helps show where P A Jones may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P A Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epigenetics in cancerbreakdown → | 2009 | 1903 |
| 2 | 2003 | 413 | |
| 3 | Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. | 2001 | 46 |
| 4 | 2000 | 12 | |
| 5 | 2000 | 47 | |
| 6 | 2000 | 15 | |
| 7 | 2000 | 95 | |
| 8 | Cancer-epigenetics comes of agebreakdown → | 1999 | 1905 |
| 9 | Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. | 1997 | 113 |
| 10 | Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. | 1996 | 87 |
| 11 | 1995 | 60 | |
| 12 | Concordance between parental origin of chromosome 13q loss and chromosome 6p duplication in sporadic retinoblastoma. | 1994 | 7 |
| 13 | Absence of p53 gene mutations in primary nasopharyngeal carcinomas. | 1992 | 103 |
| 14 | 5-Methylcytosine as an endogenous mutagen in the p53 tumor suppressor gene. | 1991 | 9 |
| 15 | 1990 | 209 | |
| 16 | 1990 | 7 | |
| 17 | 1988 | 4 | |
| 18 | Studies on immunoglobulin gene rearrangement in formalin-fixed, paraffin-embedded pathology specimens. | 1988 | 17 |
| 19 | Differential regulation of plasminogen activators by epidermal growth factor in normal and neoplastic human urothelium. | 1988 | 22 |
About P A Jones
P A Jones is a scholar working on Cancer Research, Otorhinolaryngology and Molecular Biology, having authored 19 papers that have together received 5.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Cancer-related gene regulation (5 papers), RNA modifications and cancer (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Genomics and Diagnostics (4 papers), Cancer-related Molecular Pathways (4 papers), Protease and Inhibitor Mechanisms (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Cancer Research (966 citations), Molecular Biology (4.3k citations) and Oncology (763 citations). P A Jones has collaborated with scholars based in United States, Sweden and France. Frequent co-authors include Peter W. Laird, Shilpa Sharma, Felicidad A. Gonzales, Weilan Ye, Cindy Matsen, Víctor E. Márquez, Jian‐Chun Cheng, Shaun Greer, Eric U. Selker and Mark L. Gonzalgo. Their work appears in journals such as Nature Genetics, JNCI Journal of the National Cancer Institute and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.